Tag: pharmaceuticals

  • Challenge-Funded Research Studies Animal Testing Alternative

    Research at University of Southampton in the U.K. will study in-vitro alternatives for testing the toxicity of drug candidates on animals. The U.K.’s National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) awarded £500,000 ($US 800,400) for the study from its 2011 CRACK IT challenge seeking alternatives to tests with lab…

  • Bellicum Pharma Lands $20M in Series B Finance Round

    Bellicum Pharmaceuticals Inc. in Houston, Texas says today it has raised $20 million in series B financing, the second round of investment after initial start-up. The company develops vaccines designed to attack specific disease-producing cells, including those causing life-threatening disorders such as cancer. The privately-held Bellicum says current and new investors contributed to this investment…

  • Clinical Trial to Test Brown Fat Hormone Obesity Treatment

    A clinical trial at Sanford-Burnham Medical Research Institute in Orlando, Florida will test the weight-control capabilities of orexin, a hormone that activates the body’s brown fat, which converts calories into energy. The trial will take place at the Translational Research Institute for Metabolism and Diabetes, a joint venture of Sanford-Burnham and Florida Hospital in Orlando.…

  • Biotech, Pharma Companies to Collaborate on New Vaccines

    Medicago Inc. in Quebec City, Canada and Mitsubishi Tanabe Pharma Corp. in Osaka, Japan have agreed to develop and commercialize at least three new vaccines based on Medicago’s technology. The first part of the deal is expected to provide Medicago with up to $C33 million ($US 33 milion) in revenues. The partnership will give Mitsubishi…

  • University, Company Test Gene Transfer Cancer Treatment

    University of California in San Diego and biopharmaceutical company Tocagen Inc., also in San Diego, are testing a new type of brain cancer treatment that injects a viral vector directly into a tumor. Viral vectors use viruses to deliver genetic material into cells, and in this case, the vectors intend to target the cancerous cells…

  • NIH Grant to Fund R&D on Pain Meds With Fewer Side Effects

    Scripps Research Institute in Jupiter, Florida has received a grant from National Institute on Drug Abuse, part of National Institutes of Health (NIH), for research on compounds that lead to new pain medications without the side effects of opiate drugs. The five-year, $3.1 million award will support a Scripps team led by neuroscientist Laura Bohn…

  • Avanir, Concert in Licensing Deal for Neurological Drugs

    The biopharmaceutical company Avanir Pharmaceuticals Inc. in Aliso Viejo, California and the biotechnology firm Concert Pharmaceuticals in Lexington, Massachusetts have agreed on a deal that licenses Concert’s drug-development technology to design treatments for neurological and psychiatric disorders. While the companies did not disclose financial details, the industry Web site Xconomy says the deal can provide…

  • Patent Issued for Protein-Engineered Flu Vaccine Technology

    Fraunhofer USA in Newark, Delaware has been assigned a U.S. patent for its technology that binds proteins with antigens to fight influenza. The Patent and Trademark Office awarded patent 8,124,103 on 28 February to three inventors, including Vidadi Yusibov, executive director of Fraunhofer USA. Yusibov also serves as the chief scientific officer of iBio Inc.,…

  • FDA Issues New Label Requirements for Statins

    The Food and Drug Administration has issued new labeling regulations for statins, a class of drugs used to lower cholesterol levels. When taken in combination with changes in diet and exercise, statins can can reduce levels of low-density lipoprotein (LDL or “bad”) cholesterol in the blood. LDL cholesterol circulating in the blood can deposit on…

  • Universal Vaccines Assessed for Widespread Flu Prevention

    Researchers In the U.S. and the U.K. have developed a simulation model to assess the ability of universal vaccines — those that cover a number of disease variations — to prevent the spread of influenza. The team from Princeton University and Duke University, Imperial College London, National Institutes of Health, and Food and Drug Administration…